<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bigelow EO</submitter><funding>NIDCR NIH HHS</funding><funding>NIDCD NIH HHS</funding><pagination>105618</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8754255</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>123</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Many patients diagnosed with oropharyngeal squamous cell carcinoma (OPSCC) have the option of radiation- or surgery-based therapy, and would benefit from a treatment decision aid (DA) to make decisions congruent with their personal values. Our objective was to develop a patient-centered DA for patients with OPSCC that is comprehensible, usable, acceptable, and well-designed.&lt;h4>Materials and methods&lt;/h4>Decisional needs from a pilot study of OPSCC survivors and treating physicians were used to inform a web-based prototype DA. A multidisciplinary steering group developed and iteratively revised the DA. Feasibility testing was conducted in two cycles to assess perspectives of stakeholders (medical, radiation and surgical oncologists, patient education experts, and OPSCC su</pubmed_abstract><journal>Oral oncology</journal><pubmed_title>Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.</pubmed_title><pmcid>PMC8754255</pmcid><funding_grant_id>R35 DE026631</funding_grant_id><funding_grant_id>T32 DC000027</funding_grant_id><pubmed_authors>D'Souza G</pubmed_authors><pubmed_authors>Kiess AP</pubmed_authors><pubmed_authors>Seiwert T</pubmed_authors><pubmed_authors>Bigelow EO</pubmed_authors><pubmed_authors>Fakhry C</pubmed_authors><pubmed_authors>Windon MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.</name><description>&lt;h4>Objectives&lt;/h4>Many patients diagnosed with oropharyngeal squamous cell carcinoma (OPSCC) have the option of radiation- or surgery-based therapy, and would benefit from a treatment decision aid (DA) to make decisions congruent with their personal values. Our objective was to develop a patient-centered DA for patients with OPSCC that is comprehensible, usable, acceptable, and well-designed.&lt;h4>Materials and methods&lt;/h4>Decisional needs from a pilot study of OPSCC survivors and treating physicians were used to inform a web-based prototype DA. A multidisciplinary steering group developed and iteratively revised the DA. Feasibility testing was conducted in two cycles to assess perspectives of stakeholders (medical, radiation and surgical oncologists, patient education experts, and OPSCC su</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-05T10:17:01.018Z</modification><creation>2025-04-05T10:17:01.018Z</creation></dates><accession>S-EPMC8754255</accession><cross_references><pubmed>34823157</pubmed><doi>10.1016/j.oraloncology.2021.105618</doi></cross_references></HashMap>